risperidone has been researched along with Schizotypal Personality Disorder in 13 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Schizotypal Personality Disorder: A personality disorder in which there are oddities of thought (magical thinking, paranoid ideation, suspiciousness), perception (illusions, depersonalization), speech (digressive, vague, overelaborate), and behavior (inappropriate affect in social interactions, frequently social isolation) that are not severe enough to characterize schizophrenia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results suggest that OCD patients with and without comorbid chronic tic disorders or schizotypal personality disorder may respond to the addition of low-dose risperidone to ongoing SRI therapy." | 9.09 | A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. ( Epperson, CN; McDougle, CJ; Pelton, GH; Price, LH; Wasylink, S, 2000) |
| "These results suggest that OCD patients with and without comorbid chronic tic disorders or schizotypal personality disorder may respond to the addition of low-dose risperidone to ongoing SRI therapy." | 5.09 | A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. ( Epperson, CN; McDougle, CJ; Pelton, GH; Price, LH; Wasylink, S, 2000) |
| "•We assessed self-monitoring in schizotypal personality disorder (SPD) using ERPs." | 2.82 | Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism. ( Antonijoan, RM; Corripio, I; Grasa, E; Mañanas, MÀ; Münte, TF; Pérez, V; Rabella, M; Riba, J; Romero, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmechtig, A | 2 |
| Lees, J | 2 |
| Grayson, L | 2 |
| Craig, KJ | 2 |
| Dadhiwala, R | 2 |
| Dawson, GR | 2 |
| Deakin, JF | 2 |
| Dourish, CT | 2 |
| Koychev, I | 2 |
| McMullen, K | 2 |
| Migo, EM | 1 |
| Perry, C | 2 |
| Wilkinson, L | 2 |
| Morris, R | 1 |
| Williams, SC | 1 |
| Ettinger, U | 2 |
| Rabella, M | 1 |
| Grasa, E | 1 |
| Corripio, I | 1 |
| Romero, S | 1 |
| Mañanas, MÀ | 1 |
| Antonijoan, RM | 1 |
| Münte, TF | 1 |
| Pérez, V | 1 |
| Riba, J | 1 |
| Takahashi, T | 1 |
| Wood, SJ | 1 |
| Yung, AR | 1 |
| Soulsby, B | 1 |
| McGorry, PD | 1 |
| Suzuki, M | 1 |
| Kawasaki, Y | 1 |
| Phillips, LJ | 2 |
| Velakoulis, D | 1 |
| Pantelis, C | 1 |
| Gaebel, W | 1 |
| Riesbeck, M | 1 |
| Wölwer, W | 1 |
| Klimke, A | 1 |
| Eickhoff, M | 1 |
| von Wilmsdorff, M | 1 |
| Lemke, M | 1 |
| Heuser, I | 1 |
| Maier, W | 1 |
| Huff, W | 1 |
| Schmitt, A | 1 |
| Sauer, H | 1 |
| Riedel, M | 1 |
| Klingberg, S | 1 |
| Köpcke, W | 1 |
| Ohmann, C | 1 |
| Möller, HJ | 1 |
| Edwards, J | 1 |
| McMurray, N | 1 |
| Francey, S | 1 |
| Walters, J | 1 |
| Williams, S | 1 |
| Barkus, E | 1 |
| Stone, WS | 1 |
| Hsi, X | 1 |
| Giuliano, AJ | 1 |
| Tan, L | 1 |
| Zhu, S | 1 |
| Li, L | 1 |
| Seidman, LJ | 1 |
| Tsuang, MT | 1 |
| Weiner, I | 1 |
| Schiller, D | 1 |
| Gaisler-Salomon, I | 1 |
| Koenigsberg, HW | 1 |
| Reynolds, D | 1 |
| Goodman, M | 1 |
| New, AS | 1 |
| Mitropoulou, V | 1 |
| Trestman, RL | 1 |
| Silverman, J | 1 |
| Siever, LJ | 1 |
| Rybakowski, JK | 2 |
| Drózdz, W | 2 |
| Borkowska, A | 2 |
| Crespo-Facorro, B | 1 |
| Pelayo-Terán, JM | 1 |
| Pérez-Iglesias, R | 1 |
| Ramírez-Bonilla, M | 1 |
| Martínez-García, O | 1 |
| Pardo-García, G | 1 |
| Vázquez-Barquero, JL | 1 |
| McDougle, CJ | 1 |
| Epperson, CN | 1 |
| Pelton, GH | 1 |
| Wasylink, S | 1 |
| Price, LH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Maintenance Treatment vs. Stepwise Drug Discontinuation After One Year of Maintenance Treatment in First-Episode Schizophrenia[NCT00159120] | Phase 4 | 71 participants (Anticipated) | Interventional | 2001-11-30 | Completed | ||
| Risk of Breakthrough Symptoms On Antipsychotic Maintenance Medication When Remitted Patients Are Treated With Long-Acting Injectable Medications[NCT05473741] | 180 participants (Anticipated) | Observational | 2023-01-09 | Recruiting | |||
| Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder[NCT00158028] | 25 participants (Actual) | Interventional | 1995-11-30 | Completed | |||
| A D1 Agonist For Working Memory Enhancement In The Schizophrenia Spectrum[NCT02507206] | Phase 2 | 120 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 trials available for risperidone and Schizotypal Personality Disorder
| Article | Year |
|---|---|
Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Nic | 2013 |
Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism.
Topics: Adult; Brain Mapping; Contingent Negative Variation; Cross-Over Studies; Dopamine Antagonists; Doubl | 2016 |
Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Atrophy; Bipolar Disorder; Cognitive Behavioral Therapy; Co | 2009 |
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; | 2011 |
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; | 2011 |
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; | 2011 |
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; | 2011 |
Comparison of experiences of stress and coping between young people at risk of psychosis and a non-clinical cohort.
Topics: Adaptation, Psychological; Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Cognitive Beha | 2012 |
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Topics: Adult; Amisulpride; Analysis of Variance; Biomarkers; Cognition Disorders; Double-Blind Method; Fema | 2012 |
Are neurocognitive, clinical and social dysfunctions in schizotaxia reversible pharmacologically?: Results from the Changsha study.
Topics: Adolescent; Adult; Antipsychotic Agents; China; Cluster Analysis; Cognitive Dysfunction; Double-Blin | 2012 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Comorbidity; F | 2007 |
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Comorbidity; Dopamine Antagonists; Double-Blind Method; Drug Administra | 2000 |
3 other studies available for risperidone and Schizotypal Personality Disorder
| Article | Year |
|---|---|
Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.
Topics: Animals; Antipsychotic Agents; Conditioning, Psychological; Inhibition, Psychological; Male; Rats; R | 2003 |
Low dose risperidone in the treatment of schizophrenia-like symptoms in high-risk subjects.
Topics: Adolescent; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Ris | 2003 |
Long-term administration of the low-dose risperidone in schizotaxia subjects.
Topics: Adolescent; Adult; Antipsychotic Agents; Cognition Disorders; Drug Administration Schedule; Eye Move | 2007 |